Ph 1 Study of ORIC-944 in Patients with Metastatic Prostate Cancer.
ORIC-944-01
Phase 1 other active
Quick answer
Ph 1 Study of ORIC-944 in Patients with Metastatic Prostate Cancer. for Prostate cancer is a Phase 1 program (other) at Oric Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oric Pharmaceuticals
- Indication
- Prostate cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active